Expression, purification, and characterization of VP2 capsid protein of canine parvovirus in Escherichia coli

World Journal of Microbiology and Biotechnology

Volumn 24, Issue 4, 2008, Pages 457-463

  Zeng, Fanquan ^a   Yeung, Waisees ^b   Lu, Yongjun ^a   Lun, Zhaorong ^a   Lv, Junyi ^a   Liu, Fuan ^c   Zhang, Hailong ^d   Zhao, Hongjie ^c   Zhen, Chen ^e   Liu, Xihong ^e  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

^c SOUTH CHINA AGRICULTURAL UNIVERSITY   (China)

^d SHENZHEN CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^e GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Canine parvovirus; Expression; Optimization; pMAL c2x vector; VP2 protein

Indexed keywords

ANTIBODIES; OPTIMIZATION; PURIFICATION; VIRUSES;

CANINE PARVOVIRUS; ENDOTOXINS; POLYCLONAL ANTIBODIES;

ESCHERICHIA COLI;

CANINE PARVOVIRUS; CANIS FAMILIARIS; ESCHERICHIA COLI; MIRIDAE; ORYCTOLAGUS CUNICULUS; PARVOVIRUS;

EID: 41049099362     PISSN: 09593993     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11274-007-9493-5     Document Type: Article

References (22)

1. Andre S, Seed B et al (1998) Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage. J Virol 72(2):1497-1503
2. Bjorndal B, Trave G et al (2003) Expression and purification of receptor for activated C-kinase 1 (RACK1). Protein Expr Purif 31:47-55
3. Bradel-Tretheway BG, et al (2003) Effect of codon-optimization on protein expression by the human herpesvirus 6 and 7 U51 open reading frame. J Virol Methods 111:145-156
4. Dalsgaard K, Uttentnal J et al (1997) Plant-derive vaccine protects target animals against a viral disease. Nat Biotechnol 15:248-252
5. Feher A, Boross P et al (2004) Expression of the murine leukemia virus protease in fusion with maltose-binding protein in Escherichia coli. Protein Expr Purif 35:62-68
6. Fernandez-Fernandez MR, Martinez-Torrecuadrada A et al (1998) Development of an antigen presentation system base on plum pox potyvirus. FEBS Lett 427:229-235
7. Gil F, Brun A et al (2001) High-yield expressin of a viral peptide vaccine in transgenic plants. FEBS Lett 488:13-17
8. Langeveld JPM, Ignacio Casal J et al (1994) First peptide vaccine providing protection against viral infection in the target animal: studies of canine parvovirus in dogs. J Virol 68:4506-4513
9. Langeveld JPM, Martinez-Torrecuadrada J et al (2001a) Characterisation of a protective linear B cell epitope against feline parvovirus. Vaccine 19:2352-2360
10. Langeveld JPM, Brennan FR et al (2001b) Inactivated recombinant plant virus protects dogs from a lethal challenge with canine parvovirus. Vaccine 19:3661-3670
11. Liu S, Tobias R et al (1997) Removal of endotoxin from recombinant protein preparations. Clin Biochem 30:455-463
12. Lo'pez de Turiso JA, Corte's E, Martinez C, Ruiz de Ibanez R, Simarro I, Vela C, Casal JI (1992) Recombinant vaccine for canine parvovirus in dogs. J Virol 66:2748-2753
13. Marcipar IS, Olivares ML et al (2004) The diagnostic performance of recombinant Trypanosoma cruzi ribosomal P2 protein is influenced by its expression system. Protein Expr Purif 34:1-7
14. Molina A, Hervas-Stubbs LM et al (2004) High-yield expression of a viral peptide animal vaccine in transgenic tobacco chloroplasts. Plant Biotechnol J 2:141-153
15. Molina A, Veramendi J, Hervas-Stubbs S (2005) Induction of neutralizing antibodies by a tobacco chloroplast-derived vaccine based on a B cell epitope from canine parvovirus. Virology 342:266-275
16. Salek-Ardakani S, Stuart AD et al (2001) High level expression and purification of the Esptein-Barr virus encoded cytokine viral interleukin 10:efficient removal of endotoxin. Cytokine 17:1-13
17. Tsao J, Chapman MS et al (1991) The three-dimensional structure of canine parvovirus and its functional implications. Science 251:1456-1464
18. Turiso JAL, Cortes E, Ranz A, et al (1991) Fine mapping of canine parvovirus B cell epitopes. J Gen Virol 72:2445-2456
19. Yeung W, Fuan L (2000) Assessment of the clinical efficacy of various canine parvovirus vaccines, GuangDong. J Anim Vet Sci 25:18-21
20. Yeung W, Fuan L (2001) Canine gene vaccine and canine antibiotic resistance, GuangDong. J Anim Vet Sci 26:31-32
21. Yeung W (Yang Dewei), Fanquan Z, Fuan L, Xun WP (2005) Pathology follow-up by antibiotic resistance resulting from gene vaccine usage. Postdoctoral forum of Guangzhou Traditional Chinese Medicine University pp 10-15
22. Zhao SL, Liang CY et al (2005) Characterization of the RNA-binding domain in the Dendrolimus Punctutas cytoplasmic polyhedrosis virus nonstructural protein p44. Virus Res 114:80-88